Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Liver diseases and hemostasis].

M H Denninger1

  • 1Service d'Hématologie et Immunologie, Hôpital Beaujon, Clichy, France.

Pathologie-Biologie
|December 28, 1999
PubMed
Summary

Liver disease disrupts hemostasis, causing bleeding risks and clotting factor deficiencies. Monitoring coagulation and fibrinolysis is crucial for managing liver patients and preventing complications like disseminated intravascular coagulation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage.

Journal of thrombosis and haemostasis : JTH·2006
Same author

Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation.

Gut·2005
Same author

Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy.

Gastroenterology·2001
Same author

Factor V Leiden related Budd-Chiari syndrome.

Gut·2001
Same author

Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors.

Hepatology (Baltimore, Md.)·2000
Same author

Auxiliary liver transplantation: how to improve regeneration of the native liver by surgery.

Transplant international : official journal of the European Society for Organ Transplantation·2000

Area of Science:

  • Hematology
  • Hepatology
  • Coagulation Science

Context:

  • The liver is central to hemostasis, producing clotting factors and clearing activated enzymes.
  • Liver dysfunction significantly impacts the balance of coagulation and fibrinolysis.
  • Liver diseases frequently lead to hemostasis abnormalities, including bleeding and thrombosis risks.

Purpose:

  • To elucidate the multifaceted role of the liver in hemostasis regulation.
  • To detail the hemostatic abnormalities associated with liver diseases.
  • To outline the clinical utility of hemostasis testing in liver disease management.

Summary:

  • Liver disease impairs hemostasis by reducing clotting factor production and altering fibrinolytic activity.
  • Common hemostatic issues include decreased clotting factors, thrombocytopenia, and platelet dysfunction.
  • Liver failure is a major risk factor for disseminated intravascular coagulation (DIC).

Impact:

  • Hemostasis testing aids in assessing liver function severity and bleeding risk.
  • Prothrombin time is key for evaluating hepatocellular failure.
  • Platelet function and fibrinolysis assessment are vital before invasive procedures in liver patients.

Related Experiment Videos